Min He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Min He has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alphonsus Khin Sze Chong
Department of Hand and Reconstructive Microsurgery, National University Hospital, Singapore
1 shared publication - Biyun Qian
Hongqiao International Institute of Medicine, Shanghai Tongren Hospital and School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Fengju Song
Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology in Tianjin, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer Tianjin Medical University Cancer Institute & Hospital Tianjin China
1 shared publication - Haixin Li
Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Guangdong Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China
1 shared publication Jiabin Cai
Department of Surgical Oncology
1 shared publicationJieni Xiong
Department of Surgical Oncology
1 shared publication
Latest Publications
- 3 November 2021
- Published by SAGE Publications in Bio-Medical Materials and Engineering
- Vol. 32 (6) , 375-381
3D-printed Poly-Lactic Co-Glycolic Acid (PLGA) scaffolds in non-critical bone defects impede bone regeneration in rabbit tibia bone
BACKGROUND: An increasing number of bone graft materials are commercially available and vary in their composition, mechanism of action, costs, and indications. OBJECTIVE: A commercially available PLGA scaffold produced using 3D printing technology has been used to promote the preservation of the alveolar socket after tooth extraction. We examined its influence on bone regeneration in long bones of New Zealand White rabbits. METHODS: 5.0-mm-diameter circular defects were created on the tibia bones of eight rabbits. Two groups were studied: (1) control group, in which the bone defects were left empty; (2) scaffold group, in which the PLGA scaffolds were implanted into the bone defect. Radiography was performed every two weeks postoperatively. After sacrifice, bone specimens were isolated and examined by micro-computed tomography and histology. RESULTS: Scaffolds were not degraded by eight weeks after surgery. Micro-computed tomography and histology showed that in the region of bone defects that was occupied by scaffolds, bone regeneration was compromised and the total bone volume/total volume ratio (BV/TV) was significantly lower. CONCLUSION: The implantation of this scaffold impedes bone regeneration in a non-critical bone defect. Implantation of bone scaffolds, if unnecessary, lead to a slower rate of fracture healing.
- 3 November 2021
- Published by SAGE Publications in Bio-Medical Materials and Engineering
- Vol. 32 (6) , 375-381
3D-printed Poly-Lactic Co-Glycolic Acid (PLGA) scaffolds in non-critical bone defects impede bone regeneration in rabbit tibia bone
BACKGROUND: An increasing number of bone graft materials are commercially available and vary in their composition, mechanism of action, costs, and indications. OBJECTIVE: A commercially available PLGA scaffold produced using 3D printing technology has been used to promote the preservation of the alveolar socket after tooth extraction. We examined its influence on bone regeneration in long bones of New Zealand White rabbits. METHODS: 5.0-mm-diameter circular defects were created on the tibia bones of eight rabbits. Two groups were studied: (1) control group, in which the bone defects were left empty; (2) scaffold group, in which the PLGA scaffolds were implanted into the bone defect. Radiography was performed every two weeks postoperatively. After sacrifice, bone specimens were isolated and examined by micro-computed tomography and histology. RESULTS: Scaffolds were not degraded by eight weeks after surgery. Micro-computed tomography and histology showed that in the region of bone defects that was occupied by scaffolds, bone regeneration was compromised and the total bone volume/total volume ratio (BV/TV) was significantly lower. CONCLUSION: The implantation of this scaffold impedes bone regeneration in a non-critical bone defect. Implantation of bone scaffolds, if unnecessary, lead to a slower rate of fracture healing.
- Open Access
- 13 May 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (5)
Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes
Objective: To compare the outcomes of the transhepatic hilar approach and conventional approach for surgical treatment of Bismuth types III and IV perihilar cholangiocarcinoma. Methods: We retrospectively reviewed the medical records of 82 patients who underwent surgical resection of Bismuth types III and IV perihilar cholangiocarcinoma from 2008 to 2016. The transhepatic hilar approach and conventional approach was used in 36 (43.9%) and 46 (56.1%) patients, respectively. Postoperative complications and overall survival were compared between the two approaches. Results: Similar clinical features were observed between the patients treated by the conventional approach and those treated by the transhepatic hilar approach. The transhepatic hilar approach was associated with less intraoperative bleeding and a lower percentage of Clavien grade 0 to II complications than the conventional approach. However, the transhepatic hilar approach was associated with a higher R0 resection rate and better overall survival. Multivariate analysis showed that using the transhepatic hilar approach, the Memorial Sloan-Kettering Cancer Center classification, and R0 resection were independent risk factors for patient survival. Conclusion: The transhepatic hilar approach might be the better choice for surgical resection of Bismuth types III and IV perihilar cholangiocarcinoma because it is associated with lower mortality and improved survival.
- 13 May 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (5)
Open AccessTranshepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes
Objective: To compare the outcomes of the transhepatic hilar approach and conventional approach for surgical treatment of Bismuth types III and IV perihilar cholangiocarcinoma. Methods: We retrospectively reviewed the medical records of 82 patients who underwent surgical resection of Bismuth types III and IV perihilar cholangiocarcinoma from 2008 to 2016. The transhepatic hilar approach and conventional approach was used in 36 (43.9%) and 46 (56.1%) patients, respectively. Postoperative complications and overall survival were compared between the two approaches. Results: Similar clinical features were observed between the patients treated by the conventional approach and those treated by the transhepatic hilar approach. The transhepatic hilar approach was associated with less intraoperative bleeding and a lower percentage of Clavien grade 0 to II complications than the conventional approach. However, the transhepatic hilar approach was associated with a higher R0 resection rate and better overall survival. Multivariate analysis showed that using the transhepatic hilar approach, the Memorial Sloan-Kettering Cancer Center classification, and R0 resection were independent risk factors for patient survival. Conclusion: The transhepatic hilar approach might be the better choice for surgical resection of Bismuth types III and IV perihilar cholangiocarcinoma because it is associated with lower mortality and improved survival.
- Open Access
- 15 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (2) , e23717
Renal cell carcinoma in children and adolescents
Renal cell carcinoma (RCC) is infrequent in the pediatric population. In addition, till date, only a few reports have summarized the characteristics of pediatric RCC and differences between pediatric and adult RCC. Therefore, the current study aimed to investigate the clinical characteristics of RCC in children and adolescents, and identify the differences between children and adolescent patients and adult patients through literature retrieval. The data of 13 pediatric patients diagnosed with RCC at the Children's Hospital of Zhejiang University School of Medicine between 2005 and 2019 were retrospectively analyzed. Three patients were aged <5 years, 2 were aged 6 to 10 years, and 8 were aged 11 to 18 years. Among the 13 patients, common clinical manifestations included abdominal pain in 5 patients, gross hematuria in 4, and an abdominal mass in 1, while the other 3 patients were incidentally detected after an abdominal contusion. The pathological types were microphthalmia family translocation RCC in 9 patients, clear-cell RCC in 2, papillary RCC in 1, and unclassified in 1. All the children underwent radical nephrectomy, including 2 patients with advanced disease who underwent preoperative transcatheter arterial chemoembolization. The mean follow-up time was 58.6 months. Two patients died after 4 and 17 months of follow-up, respectively. In conclusion, microphthalmia family translocation renal cell carcinoma is the predominant type of pediatric RCC associated with advanced tumor stage. The early diagnosis and treatment of pediatric patients is important for improving prognosis. Nevertheless, future studies are urgently needed to determine the treatment for pediatric advanced RCC to increase the survival rate.
- 15 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (2) , e23717
Open AccessRenal cell carcinoma in children and adolescents
Renal cell carcinoma (RCC) is infrequent in the pediatric population. In addition, till date, only a few reports have summarized the characteristics of pediatric RCC and differences between pediatric and adult RCC. Therefore, the current study aimed to investigate the clinical characteristics of RCC in children and adolescents, and identify the differences between children and adolescent patients and adult patients through literature retrieval. The data of 13 pediatric patients diagnosed with RCC at the Children's Hospital of Zhejiang University School of Medicine between 2005 and 2019 were retrospectively analyzed. Three patients were aged <5 years, 2 were aged 6 to 10 years, and 8 were aged 11 to 18 years. Among the 13 patients, common clinical manifestations included abdominal pain in 5 patients, gross hematuria in 4, and an abdominal mass in 1, while the other 3 patients were incidentally detected after an abdominal contusion. The pathological types were microphthalmia family translocation RCC in 9 patients, clear-cell RCC in 2, papillary RCC in 1, and unclassified in 1. All the children underwent radical nephrectomy, including 2 patients with advanced disease who underwent preoperative transcatheter arterial chemoembolization. The mean follow-up time was 58.6 months. Two patients died after 4 and 17 months of follow-up, respectively. In conclusion, microphthalmia family translocation renal cell carcinoma is the predominant type of pediatric RCC associated with advanced tumor stage. The early diagnosis and treatment of pediatric patients is important for improving prognosis. Nevertheless, future studies are urgently needed to determine the treatment for pediatric advanced RCC to increase the survival rate.
- 28 October 2008
- Published by Wiley in Head & Neck
- Vol. 31 (2) , 175-182
Trends in head and neck cancer incidence in Tianjin, China, between 1981 and 2002
Background.: Head and neck cancer is 1 of the major global health issues but received limited attention, and its incidence has rarely been systematically studied in China.Methods.: The population‐based cancer registry of the urban Tianjin was used to examine the changing pattern of incidence rates and its potential causes in China.Results.: Between 1981 and 2002, the age‐standardized incidence rate (ASIR) of head and neck cancer decreased by 1.39% per year among males and 2.20% among females. Significant decreasing trends were found for the age group of 45 to 54 years in women and for the age group of 55 to 64 years in both men and women. Slight increasing trends were found in the age group of 0 to 44 years.Conclusions.: The data suggest that the overall head and neck cancer incidence was declining in Tianjin between 1981 and 2002; however, there was a possible increasing trend of risk for the younger population. © 2008 Wiley Periodicals, Inc. Head Neck, 2009
- 28 October 2008
- Published by Wiley in Head & Neck
- Vol. 31 (2) , 175-182
Trends in head and neck cancer incidence in Tianjin, China, between 1981 and 2002
Background.: Head and neck cancer is 1 of the major global health issues but received limited attention, and its incidence has rarely been systematically studied in China.Methods.: The population‐based cancer registry of the urban Tianjin was used to examine the changing pattern of incidence rates and its potential causes in China.Results.: Between 1981 and 2002, the age‐standardized incidence rate (ASIR) of head and neck cancer decreased by 1.39% per year among males and 2.20% among females. Significant decreasing trends were found for the age group of 45 to 54 years in women and for the age group of 55 to 64 years in both men and women. Slight increasing trends were found in the age group of 0 to 44 years.Conclusions.: The data suggest that the overall head and neck cancer incidence was declining in Tianjin between 1981 and 2002; however, there was a possible increasing trend of risk for the younger population. © 2008 Wiley Periodicals, Inc. Head Neck, 2009